Pipeline
Project
Target
Indication
Target
Validation
Validation
PCC
IND-
Enabling
Enabling
Clinical
Early Stage
Early Stage
Clinical
Late Stage
Late Stage
Partner
Liver Targeting
RG002
Complement C3
Complement C3 mediated renal disease
RG019
Dual-targeting
Metabolic disease
RG008
INHBE
Metabolic disease
Kidney Targeting
RG021
Undisclosed
Renal related disease
RG023
Undisclosed
Renal related disease
Adipose Targeting
RG015
Undisclosed
Metabolic disease
